Volume 3, Issue 10, Page 10 (October 2007)
11 of 31
PREVIEW
FULL TEXT
FULL-TEXT PDF (63 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
The manufacturer of the buccal formulation of fentanyl is notifying health care professionals about deaths and other serious adverse events that have been reported in patients who were treated with the opioid analgesic drug.
PII: S1553-3212(07)70298-4
doi:10.1016/S1553-3212(07)70298-4
© 2007 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.